DK0904055T3 - Ikke-polær bukkal spray eller kapsel - Google Patents

Ikke-polær bukkal spray eller kapsel

Info

Publication number
DK0904055T3
DK0904055T3 DK97914780T DK97914780T DK0904055T3 DK 0904055 T3 DK0904055 T3 DK 0904055T3 DK 97914780 T DK97914780 T DK 97914780T DK 97914780 T DK97914780 T DK 97914780T DK 0904055 T3 DK0904055 T3 DK 0904055T3
Authority
DK
Denmark
Prior art keywords
percent
polar
capsule
active compound
buccal spray
Prior art date
Application number
DK97914780T
Other languages
Danish (da)
English (en)
Inventor
Harry A Dugger Iii
Original Assignee
Novadel Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novadel Pharma Inc filed Critical Novadel Pharma Inc
Application granted granted Critical
Publication of DK0904055T3 publication Critical patent/DK0904055T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DK97914780T 1996-04-12 1997-02-21 Ikke-polær bukkal spray eller kapsel DK0904055T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/631,175 US5955098A (en) 1996-04-12 1996-04-12 Buccal non polar spray or capsule
PCT/US1997/002795 WO1997038663A2 (fr) 1996-04-12 1997-02-21 Pulverisateur ou capsule buccal non polaire

Publications (1)

Publication Number Publication Date
DK0904055T3 true DK0904055T3 (da) 2003-08-18

Family

ID=24530090

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97914780T DK0904055T3 (da) 1996-04-12 1997-02-21 Ikke-polær bukkal spray eller kapsel

Country Status (10)

Country Link
US (1) US5955098A (fr)
EP (2) EP0904055B1 (fr)
AT (2) ATE237308T1 (fr)
AU (1) AU2190797A (fr)
CA (1) CA2252050C (fr)
DE (2) DE69737637T2 (fr)
DK (1) DK0904055T3 (fr)
ES (2) ES2286180T3 (fr)
PT (1) PT904055E (fr)
WO (1) WO1997038663A2 (fr)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
AU8107998A (en) * 1997-05-22 1998-12-11 Boots Company Plc, The Pharmaceutical compositions
US20040141923A1 (en) * 1997-10-01 2004-07-22 Dugger Harry A. Buccal, polar and non-polar spray containing alprazolam
US20030077229A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
US20050002867A1 (en) * 1997-10-01 2005-01-06 Novadel Pharma Inc. Buccal, polar and non-polar sprays containing propofol
US20090162300A1 (en) * 1997-10-01 2009-06-25 Dugger Iii Harry A Buccal, polar and non-polar spray containing alprazolam
US20050180923A1 (en) * 1997-10-01 2005-08-18 Dugger Harry A.Iii Buccal, polar and non-polar spray containing testosterone
US20050163719A1 (en) * 1997-10-01 2005-07-28 Dugger Harry A.Iii Buccal, polar and non-polar spray containing diazepam
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20030077228A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
US20030190286A1 (en) * 1997-10-01 2003-10-09 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
US20040136915A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing atropine
US20040136914A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
US20050287075A1 (en) * 1997-10-01 2005-12-29 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20030095927A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
CA2306024C (fr) * 1997-10-01 2011-04-26 Flemington Pharmaceutical Corporation Pulverisation ou capsule buccale, polaire et non polaire
US20040136913A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
US6358060B2 (en) 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
US6344222B1 (en) 1998-09-03 2002-02-05 Jsr Llc Medicated chewing gum delivery system for nicotine
US6977083B1 (en) 1998-10-02 2005-12-20 Jenapharm Gmbh & Co. Kg Bioadhesive tablet containing testosterone/testosterone ester mixtures and method for producing a predetermined testosterone time-release profile with same
PT1123084E (pt) * 1998-10-02 2005-05-31 Schering Ag Utilizacao de esteres de testosterona e/ou testosterona para a preparacao de sistemas bioadesivos aplicaveis por via bucal com agentes activos medicamentosos de accao retardada
US6846495B2 (en) 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
WO2000051570A1 (fr) * 1999-02-26 2000-09-08 Shionogi & Co., Ltd. Capsules molles a croquer presentant des proprietes d'administration ameliorees et leur procede de production
JP2005505491A (ja) * 1999-06-02 2005-02-24 ヘキサル・アクチェンゲゼルシャフト 水溶性活性物質の鼻腔内投与用医薬組成物
SE0102197D0 (sv) * 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
SE521512C2 (sv) * 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US20060073174A1 (en) * 2001-08-16 2006-04-06 Access Pharmaceuticals, Inc. Adherent and erodible film to treat a moist surface of a body tissue
US7138133B2 (en) 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
SE0104388D0 (sv) * 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
US20030159702A1 (en) * 2002-01-21 2003-08-28 Lindell Katarina E.A. Formulation and use manufacture thereof
EP1496873B2 (fr) 2002-04-25 2011-08-10 Banner Pharmacaps, Inc. Gelule molle a macher
US7767698B2 (en) * 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
US7031990B2 (en) 2002-12-06 2006-04-18 Sun Microsystems, Inc. Combining external and intragenerational reference-processing in a garbage collector based on the train algorithm
US7085790B2 (en) 2002-12-06 2006-08-01 Sun Microsystems, Inc. Advancing cars in trains managed by a collector based on the train algorithm
US7069280B2 (en) 2002-12-06 2006-06-27 Sun Microsystems, Inc. Collection-tick mechanism for a collector based on the train algorithm
DK1803443T3 (en) * 2002-12-20 2019-02-25 Niconovum Ab Nicotine-containing particulate material with a crystalline cellulose
US20080213363A1 (en) * 2003-01-23 2008-09-04 Singh Nikhilesh N Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
US7062519B2 (en) 2003-02-27 2006-06-13 Sun Microsystems, Inc. Incremental scanning of enormous objects to improve scheduling and pause-time behavior of garbage collection
KR20130116378A (ko) * 2004-02-17 2013-10-23 트랜스셉트 파마슈티칼스, 인코포레이티드 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법
US20060018840A1 (en) * 2004-06-28 2006-01-26 Nektar Therapeutics Aerosolizable formulation comprising nicotine
US7620943B1 (en) 2004-06-30 2009-11-17 Sun Microsystems, Inc. Using class properties to segregate objects in a generation managed by the train algorithm
US7676801B1 (en) 2004-08-31 2010-03-09 Sun Microsystems, Inc. Scanning of evacuated objects in a generation managed by the train algorithm
AU2012200031B9 (en) * 2005-02-17 2014-03-27 Zoetis Belgium S.A. Transmucosal administration of drug compositions for treating and preventing disorders in animals
ES2490595T3 (es) * 2005-02-17 2014-09-04 Abbott Laboratories Administración transmucosal de composiciones de fármacos para tratar y prevenir trastornos en animales
WO2006100075A2 (fr) * 2005-03-22 2006-09-28 Niconovum Ab Utilisation d'un edulcorant artificiel pour renforcer l'absorption de la nicotine
US20060276501A1 (en) * 2005-05-25 2006-12-07 Transoral Pharmaceuticals, Inc. Solid compositions for treating middle-of-the-night insomnia
US20070225322A1 (en) * 2005-05-25 2007-09-27 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
US20070287740A1 (en) * 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
CA2646942C (fr) 2006-03-16 2014-07-29 Modoral Brands Inc. Composition amelioree de tabac a priser
WO2007123955A2 (fr) * 2006-04-19 2007-11-01 Novadel Pharma Inc. Formulations hydroalcooliques stables à pulvériser dans la cavité buccale et procédés associés
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
RU2009115720A (ru) * 2006-09-27 2010-11-10 Никоновум Аб (Se) Направленное применение
CA2673049C (fr) * 2006-12-22 2016-02-23 Novadel Pharma Inc. Preparations antinauseeuses a pulveriser, a usage oral, stables, et methodes associees
WO2008091588A1 (fr) 2007-01-22 2008-07-31 Targacept, Inc. Administration intranasale, buccale ou sublinguale d'analogues de métanicotine
WO2008141264A1 (fr) * 2007-05-10 2008-11-20 Novadel Pharma Inc. Compositions et procédés anti-insomnie
US20100008868A1 (en) * 2007-11-27 2010-01-14 Harry Dugger Sustained remission of atopic dermatitis
GB2469792A (en) * 2009-04-23 2010-11-03 Calvin John Ross Oil-based pharmaceutical formulation for sublingual delivery
SG175160A1 (en) * 2009-04-23 2011-11-28 Londonpharma Ltd Sublingual pharmaceutical composition comprising a neutral oil
WO2011064316A2 (fr) 2009-11-25 2011-06-03 Paolo Botti Administration de peptides par voie muqueuse
GB2482868A (en) 2010-08-16 2012-02-22 Franciscus Wilhelmus Henricus Maria Merkus A testosterone liquid spray formulation for oromucosal administration
EP2526971A1 (fr) 2011-05-25 2012-11-28 ArisGen SA Administration de médicaments par les muqueuses
GB201200062D0 (en) 2012-01-04 2012-02-15 Innotesto Bvba Estradiol oromucosal liquid compositions
USD1081739S1 (en) 2021-04-06 2025-07-01 Altria Client Services Llc Die for gum forming
US20220312826A1 (en) * 2021-04-06 2022-10-06 Altria Client Services Llc Liquid mixtures of triglyceride and liquid nicotine
US12295412B2 (en) 2022-01-28 2025-05-13 Altria Client Services Llc Oral pouch product

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
DE3338978A1 (de) * 1982-10-29 1984-05-03 Basf Ag, 6700 Ludwigshafen Verapamil und gallopamil und ihre physiologisch vertraeglichen salze zur resorptiven anwendung auf den schleimhaeuten des mundes, des nasen-rachen-raums und des rektums
DE3246081A1 (de) * 1982-12-13 1984-06-14 G. Pohl-Boskamp GmbH & Co Chemisch-pharmazeutische Fabrik, 2214 Hohenlockstedt Nitroglycerin-spray
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
AU7880991A (en) * 1990-05-10 1991-11-27 Novo Nordisk A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
ES2200771T3 (es) * 1991-06-10 2004-03-16 Schering Corporation Formulaciones en aerosol no clorofluorocarbonadas.
GB9118830D0 (en) * 1991-09-03 1991-10-16 Minnesota Mining & Mfg Medical aerosol formulations
DE4230876A1 (de) * 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
JP3911290B2 (ja) * 1994-05-13 2007-05-09 アラダイム コーポレーション エアゾールを含む麻酔用処方
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils

Also Published As

Publication number Publication date
DE69720988D1 (de) 2003-05-22
EP0904055A2 (fr) 1999-03-31
CA2252050C (fr) 2005-12-27
DE69737637D1 (de) 2007-05-31
ES2286180T3 (es) 2007-12-01
DE69720988T2 (de) 2003-12-11
DE69737637T2 (de) 2008-01-10
WO1997038663A2 (fr) 1997-10-23
EP1275374A1 (fr) 2003-01-15
EP1275374B1 (fr) 2007-04-18
AU2190797A (en) 1997-11-07
US5955098A (en) 1999-09-21
ATE359761T1 (de) 2007-05-15
ES2200165T3 (es) 2004-03-01
PT904055E (pt) 2003-08-29
WO1997038663A3 (fr) 1998-02-05
EP0904055B1 (fr) 2003-04-16
CA2252050A1 (fr) 1997-10-23
ATE237308T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
AU2190797A (en) Buccal, non-polar spray or capsule
EP1952802A3 (fr) Vaporisation ou capsule orale, polaire et non polaire
CA2058428A1 (fr) Formulations analgesiques
CA2189328A1 (fr) Compositions de tocopherol destinees a l'apport d'agents biologiquement actifs
WO1996040086A3 (fr) Compositions et methodes pour l'administration locale d'agents pharmaceutiquement actifs
EP0663401A4 (fr) Derive de morphinane et application medicale.
GB8915632D0 (en) Aerosol composition comprising nitroglycerin as active ingredient
CA2301017A1 (fr) Utilisation de gallate de propyle pour augmenter la biodisponibilite de produits pharmaceutiques administres par voie orale
CA2104474A1 (fr) Compositions et methodes pour l'administration topique d'agents pharmaceutiques actifs
CA2339765A1 (fr) Composes et compositions pour l'administration de principes actifs
WO2000016762A3 (fr) Procede pour reduire la dependance a la nicotine
CA2059263A1 (fr) Composition renfermant l'enantiomere (-) de cis-4-amino-1-(2-hydromethyl-1,3-oxathiolan-5yl)-1h-pyrimidin-2-one ou une composition enrichie en cet enantiomere; son emploi comme agent pharmaceutique
CA2004598A1 (fr) Aerosols medicinaux
EP0165696A3 (fr) Forme pour l'administration transdermale
EP1695708A3 (fr) Composition pharmaceutique
ITMI961152A0 (it) Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
WO1999007351A3 (fr) Composes chimiques
CA2360220A1 (fr) Composes a base d'oxadiazole et compositions destinees a l'apport d'agents actifs
ZA9811796B (en) New tetracyclic analogues of camptothecins, their preparation processes, their use as medicaments and the pharmaceutical compositions containing them.
NO20000466L (no) Farmasøytisk preparat for sure, lipofile forbindelser i form av en selvregulerende formulering
IE894049L (en) Therapeutically active substituted benzimidazole and process¹for its preparation
IE781032L (en) Pharmaceutical compositions
AU5326598A (en) New analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
FI861695A0 (fi) Farmaceutiskt preparat och foerfarande foer administrering daerav.
IT9047999A0 (it) Derivati xantinici 1-7 sostituiti ad attivita' antiasmatica, loro sali fisiologicamente accettabili, loro composizioni farmaceutiche e procedimento per la loro preparazione.